The life sciences real estate sector in Texas is a market with massive potential, but it’s not without its challenges. Winstead’s Andy Dow recently offered his perspective to Texas Real Estate Business, diving into the unique needs of life sciences companies and the factors that could unlock the market’s potential. Andy shares his insights on what will be a great sign of future growth and why Texas has a key advantage over other markets.
Find out how energy and power infrastructure, along with a movement of large AI-driven medical research companies, could be the key to Texas’s “golden age” of life sciences.
Read the Texas Real Estate Business magazine article here.
CONTACT:
Andy Dow I 214.745.5387 I adow@winstead.com
Over the past 20+ years, Andy Dow has developed a reputation as one of the preeminent healthcare real estate attorneys in the United States. Clients from across the country seek his counsel and advice on a variety of transactions and strategies related to the healthcare real estate sector. Whether representing a health system in a monetization transaction or a healthcare investor in a portfolio acquisition, he brings a distinctive blend of real estate excellence and healthcare industry acumen to each engagement. As the Chair of Winstead’s Real Estate Industry Group and its Healthcare & Life Sciences Real Estate Practice Group, Andy leads a team of seasoned healthcare real estate professionals with an impressive stable of clients, including industry leading healthcare REITs, private equity investors, developers, operators, hospital systems, physician groups and lenders
